CAS-Envision's fully integrated, fully automated digital PCR system--Xinqiji JX-8P
The third-generation PCR technology-Digital PCR is a technical means of absolutely quantifying nucleic acid targets by randomly dividing the fluorescent quantitative reaction system into tens of thousands of independent micro-reaction units.
Simplified absolute quantification without the need for standards and calibration curves
Higher detection sensitivity (improved <0.1% mutation detection rate in high-abundance wild-type background)
Better data reproducibility (continuous monitoring of target nucleic acid content, horizontal comparison)
Improve the tolerance to inhibitors (overcome the interference of inhibitors on quantitative results)
Higher data precision (can identify concentration changes within 1.1 times)
Our Advantages
1, The throughput is flexible, and 2-8 samples can be uploaded according to the demand
2, Simple operation, one-step sample loading, waiting for results
3, Stable performance, integrated closed reaction space design, to prevent pollution
4, The whole machine is independently developed, and the domestic platform is low-cos
Clinical Application
Project Introduction
Development Direction
Cooperation Cases
Company Introduction
CAS-Envision Xili Lake IBT molecular diagnostic pilot laboratory has a high standard P2 laboratory and 100,000 level GMP plant for nucleic acid/immune reagents, biochemical laboratory area, etc. It can provide external:
1, Testing services: molecular testing, immunoassay, cell analysis and other biological/clinical sample analysis and other testing services;
2, Product transformation: relying on the software and hardware conditions of the pilot test line and downstream clinical resources, it can realize the one-stop service of product transformation of scientific research achievements;
3, Core technology attack: the platform hardware has highly configured laboratories and equipment, software includes single molecule diagnostic technology, fully automated nucleic acid POCT, flow cytometry sorting technology, microfluidic processing and other technologies, as well as high-end diagnostic talents, which can help partner companies accelerate core technology breakthroughs;
4, Biochip development: chip design and testing, instrument development, reagent transfer and other IVD development services. 5, The production throughput of IVD kits is about 300,000 pcs/day.
Contact me for Quotation, Complete Certifications, Instruction Manual and Clinic Report!
Grace Zheng Overseas Sales Manager
4F, Bldg4, Phase 1, Tusincere Science Park, Longfei Avenue 333, Longcheng Street, Longgang District, Shenzhen, Guangdong, China